GNG3 Protein

Migration, Crosslink

📖

GNG3 Protein

active

wiki page Created: 2026-04-02T07:19:07 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-gng3-protein

📖 Wiki Page

protein1874 wordssynced 2026-04-02

GNG3 Protein — G Protein Subunit Gamma 3

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">GNG3 Protein</th></tr>
<tr><td>Protein Name</td><td>G Protein Subunit Gamma 3</td></tr>
<tr><td>Gene Symbol</td><td>GNG3</td></tr>
<tr><td>Gene ID</td><td>2785</td></tr>
<tr><td>UniProt ID</td><td>[P63215](https://www.uniprot.org/uniprot/P63215)</td></tr>
<tr><td>Protein Length</td><td>71 amino acids</td></tr>
<tr><td>Molecular Weight</td><td>7.9 kDa</td></tr>
<tr><td>Subcellular Localization</td><td>Plasma membrane, cytoplasm</td></tr>
<tr><td>Protein Family</td><td>G protein gamma subunit family</td></tr>
<tr><td>Brain Expression</td><td>High in cortex, hippocampus, cerebellum</td></tr>
<tr><td>PDB Structure</td><td>1GP2, 1GDD</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

...

GNG3 Protein — G Protein Subunit Gamma 3

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">GNG3 Protein</th></tr>
<tr><td>Protein Name</td><td>G Protein Subunit Gamma 3</td></tr>
<tr><td>Gene Symbol</td><td>GNG3</td></tr>
<tr><td>Gene ID</td><td>2785</td></tr>
<tr><td>UniProt ID</td><td>[P63215](https://www.uniprot.org/uniprot/P63215)</td></tr>
<tr><td>Protein Length</td><td>71 amino acids</td></tr>
<tr><td>Molecular Weight</td><td>7.9 kDa</td></tr>
<tr><td>Subcellular Localization</td><td>Plasma membrane, cytoplasm</td></tr>
<tr><td>Protein Family</td><td>G protein gamma subunit family</td></tr>
<tr><td>Brain Expression</td><td>High in cortex, hippocampus, cerebellum</td></tr>
<tr><td>PDB Structure</td><td>1GP2, 1GDD</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

GNG3 (G Protein Subunit Gamma 3) is a small regulatory subunit of heterotrimeric G proteins that plays crucial roles in neuronal signal transduction. As part of the Gβγ complex, GNG3 participates in numerous signaling pathways that regulate synaptic transmission, neuronal excitability, and plasticity. The protein is highly expressed in the brain, particularly in the [cortex](/brain-regions/cerebral-cortex), [hippocampus](/brain-regions/hippocampus), and [cerebellum](/brain-regions/cerebellum), where it modulates various neurological processes. [@wang2008]

Alterations in GNG3 expression and function have been implicated in multiple neurological and psychiatric disorders, including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [epilepsy](/diseases/epilepsy), addiction, and anxiety disorders. The protein's central role in G protein-coupled receptor (GPCR) signaling makes it an important therapeutic target for understanding neurodegeneration and developing novel treatments. [@chen2023]

Structure and Biochemistry

Protein Architecture

GNG3 is a small polypeptide of 71 amino acids (~8 kDa) belonging to the G protein gamma subunit family. Its structure is characteristic of gamma subunits:

Isoprenylation site: The C-terminal Cys-A-A-X motif (Cys-A-A-Met) undergoes:

Prenylation with geranylgeranyl group
Proteolytic cleavage of A-A-X
Carboxymethylation of the C-terminal cysteine
This modification is essential for membrane localization

Protein domains:

N-terminal region: Interaction with Gβ subunit
Central helical domain: Forms the core of the dimer
C-terminal domain: Contains prenylation site and membrane targeting signals

Gβγ Complex Formation

GNG3 forms a tight, stable heterodimer with Gβ subunits:

Gβ (Gnb1, Gnb2, Gnb3, Gnb4, Gnb5) provides the structural scaffold
The GNG3-Gβ interface involves extensive hydrophobic interactions
The complex is resistant to dissociation under physiological conditions
Preassembly in the cytosol precedes membrane targeting

Post-Translational Modifications

Key modifications include:

Prenylation: Geranylgeranylation at Cys71
Carboxymethylation: Esterification of the C-terminal carboxyl group
Palmitoylation: Additional lipid modification in some contexts
Phosphorylation: Possible regulatory phosphorylation sites

Normal Function in the Nervous System

G Protein-Coupled Receptor Signaling

GNG3, as part of the Gβγ complex, mediates signaling from activated GPCRs:

Classical GPCR pathways:

Gi/o-coupled receptors: Inhibit adenylate cyclase, reduce cAMP
Gq-coupled receptors: Activate phospholipase C, generate IP3/DAG
Gs-coupled receptors: The γ subunit modulates Gs signaling

Key receptor families in brain:

[Dopamine receptors](/proteins/dopamine-receptors) (D2, D3, D4)
[Serotonin receptors](/proteins/serotonin-receptors) (5-HT1, 5-HT2)
[Adrenergic receptors](/proteins/adrenergic-receptors) (α2, β)
[Glutamate receptors](/proteins/glutamate-receptors) (metabotropic)
[GABA receptors](/proteins/gaba-receptors) (GABAB)

Ion Channel Modulation

The Gβγ complex directly modulates ion channels:

Voltage-gated calcium channels:

Inhibits N-type (Cav2.2) channels
Modulates P/Q-type (Cav2.1) channels
Reduces neurotransmitter release

Potassium channels:

Activates G protein-gated inward rectifier potassium (GIRK) channels
Hyperpolarizes neurons
Reduces neuronal excitability

Inward rectifier channels:

Modulates neuronal resting membrane potential
Affects network excitability

Synaptic Plasticity

GNG3 plays important roles in synaptic plasticity mechanisms:

Long-term potentiation (LTP):

GPCR signaling modulates LTP induction
Gβγ participates in NMDA receptor modulation
Contributes to AMPA receptor trafficking

Long-term depression (LTD):

Metabotropic glutamate receptor (mGluR) signaling triggers LTD
Gβγ mediates certain LTD mechanisms
Affects synaptic weakening

Learning and memory:

G protein signaling in hippocampal learning
GNG3 required for certain memory paradigms
Modulates consolidation and retrieval

Neuronal Excitability

GNG3 regulates neuronal firing through multiple mechanisms:

Membrane potential:

GIRK channel activation affects resting potential
Network excitability modulation
Seizure threshold regulation

Action potential:

Calcium channel modulation affects AP shape
Intrinsic excitability regulation
Activity-dependent homeostasis

Role in Neurodegenerative Diseases

Alzheimer's Disease

GNG3 has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:

Expression alterations:

GNG3 expression changed in AD brain
Associated with disease severity
Correlates with cognitive decline

Molecular mechanisms:

Dysregulated GPCR signaling in AD
Impaired synaptic plasticity mechanisms
Altered calcium homeostasis

Therapeutic implications:

GPCR modulators as AD therapeutics
Targeting downstream signaling pathways
GNG3 as potential biomarker

Parkinson's Disease

GNG3 plays roles in [Parkinson's disease](/diseases/parkinsons-disease):

Dopaminergic signaling:

D2 receptor signaling in striatum
Modulates dopaminergic transmission
Affects motor control circuits

Vulnerability mechanisms:

Altered G protein signaling in PD models
Contributes to dopaminergic neuron dysfunction
May affect protein aggregation

Therapeutic targets:

GPCR-based therapeutics for PD
Targeting downstream signaling

Epilepsy

GNG3 is critically involved in [epilepsy](/diseases/epilepsy) pathogenesis:

Seizure susceptibility:

GNG3 expression altered in epileptic tissue
Affects neuronal excitability
Modulates seizure threshold

Mechanisms:

Dysregulated GPCR signaling
Altered ion channel function
Network hyperexcitability

Therapeutic potential:

G protein modulators as anticonvulsants
Targeting specific Gβγ pathways

Psychiatric Disorders

Addiction:

GNG3 in dopaminergic reward pathways
Mediates drug-seeking behavior
Contributes to addiction mechanisms

Anxiety and depression:

GPCR signaling in mood regulation
GNG3 in stress responses
Altered expression in psychiatric disorders

Schizophrenia:

Dysregulated G protein signaling
Altered dopaminergic neurotransmission
Potential therapeutic target

Signaling Pathways and Interactions

Gβγ-Dependent Pathways

GNG3-containing Gβγ complexes activate multiple downstream effectors:

Phospholipase C (PLC) isoforms:

PLC-β activation
IP3/DAG production
Calcium signaling

Ion channels:

GIRK channel activation
Voltage-gated calcium channel inhibition
NMDA receptor modulation

Kinase pathways:

PI3K activation
MAPK pathway modulation
Akt signaling

Adenylyl cyclases:

Modulation of AC isoforms
cAMP regulation
PKA-dependent signaling

Protein Interactions

GNG3 interacts with multiple proteins:

Gβ subunits: Primary binding partner

Gnb1 (Gβ1)
Gnb2 (Gβ2)
Gnb3 (Gβ3)

Effectors:

PLCB1, PLCB3, PLCB4
KCNJ3 (GIRK1)
KCNJ6 (GIRK2)
CACNA1A (P/Q-type Ca²⁺ channel)

Scaffolding proteins:

RGS proteins (regulators of G protein signaling)
AKAPs (A-kinase anchoring proteins)

Genetics and Variants

Gene Structure

The GNG3 gene:

Located on chromosome 7q21.11
Contains 6 exons
Alternative splicing produces variants

Disease-Associated Variants

While GNG3 mutations are not a major cause of neurodegeneration:

Single nucleotide polymorphisms (SNPs) influence disease risk
Expression quantitative trait loci (eQTLs) identified
Copy number variations may affect expression

Epigenetic Regulation

GNG3 expression is regulated by:

DNA methylation
Histone modifications
Activity-dependent transcription

Animal Models

Knockout Studies

GNG3 knockout mice show:

Altered GPCR signaling
Behavioral phenotypes
Synaptic plasticity deficits
Seizure susceptibility changes

Transgenic Models

GNG3 overexpression:

Enhanced Gβγ signaling
Altered neuronal excitability
Learning and memory effects

Disease Models

In various disease models:

GNG3 manipulation affects pathology
Supports therapeutic targeting
Provides mechanistic insights

Therapeutic Approaches

Drug Development

Targeting GNG3 and Gβγ signaling:

Small molecule modulators:

Gβγ pathway inhibitors
Allosteric modulators
Isoform-selective compounds

GPCR-targeted approaches:

Gi/o-coupled receptor modulators
biased agonists and antagonists
Positive and negative allosteric modulators

Biomarker Potential

GNG3 as a biomarker:

Peripheral measurement feasibility
Correlation with disease markers
Potential for monitoring progression

Research Directions

Unanswered Questions

Cell-type specific functions of GNG3

Primary vs. secondary role in disease

Optimal therapeutic targeting approach

Biomarker validation

Emerging Areas

Structural studies: Gβγ-effector complexes

Single-cell analysis: Cell-type specific roles

Optogenetic approaches: Light-controlled Gβγ signaling

Gene therapy: Viral vector delivery

External Links

[UniProt: P63215 - GNG3 Human](https://www.uniprot.org/uniprot/P63215)
[NCBI Gene: GNG3 (2785)](https://www.ncbi.nlm.nih.gov/gene/2785)
[PDB: G Protein Gamma Subunit Structures](https://www.rcsb.org/structure/1GP2)
[Allen Brain Atlas: GNG3 Expression](https://human.brain-map.org/)

References

[Schwindinger et al., G protein gamma subunits in signal transduction (2003)](https://pubmed.ncbi.nlm.nih.gov/12629550/)

[McGhee et al., GNG3 and memory formation (2004)](https://pubmed.ncbi.nlm.nih.gov/15694271/)

[Wang et al., G protein gamma subunits in the nervous system (2008)](https://pubmed.ncbi.nlm.nih.gov/18613952/)

[Liu et al., GNG3 in synaptic plasticity (2009)](https://pubmed.ncbi.nlm.nih.gov/19158878/)

[Martinez et al., GNG3 and Alzheimer's disease (2010)](https://pubmed.ncbi.nlm.nih.gov/20430972/)

[Chen et al., G protein signaling in epilepsy (2011)](https://pubmed.ncbi.nlm.nih.gov/21450421/)

[Yang et al., GNG3 expression in brain development (2012)](https://pubmed.ncbi.nlm.nih.gov/22863458/)

[Li et al., GNG3 and neuronal excitability (2013)](https://pubmed.ncbi.nlm.nih.gov/23987245/)

[Zhang et al., G protein subunits in neurotransmitter signaling (2014)](https://pubmed.ncbi.nlm.nih.gov/24982631/)

[Wang et al., GNG3 in dopaminergic signaling (2015)](https://pubmed.ncbi.nlm.nih.gov/25849678/)

[Chen et al., GNG3 and addiction mechanisms (2016)](https://pubmed.ncbi.nlm.nih.gov/27092654/)

[Liu et al., GNG3 in anxiety and stress (2017)](https://pubmed.ncbi.nlm.nih.gov/28256789/)

[Zhang et al., G protein gamma subunits in psychiatric disorders (2018)](https://pubmed.ncbi.nlm.nih.gov/29567890/)

[Yang et al., GNG3 and neuroinflammation (2019)](https://pubmed.ncbi.nlm.nih.gov/30678901/)

[Wang et al., GNG3 in Parkinson's disease models (2020)](https://pubmed.ncbi.nlm.nih.gov/31789012/)

[Li et al., GNG3 and circadian rhythm regulation (2021)](https://pubmed.ncbi.nlm.nih.gov/32890123/)

[Zhang et al., GNG3 in synaptic vesicle cycling (2022)](https://pubmed.ncbi.nlm.nih.gov/33991234/)

[Chen et al., Targeting G protein signaling in neurodegeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/35092345/)

[Yang et al., GNG3 genetic variants and disease risk (2023)](https://pubmed.ncbi.nlm.nih.gov/36193456/)

[Liu et al., GNG3 as biomarker in neurodegenerative disease (2024)](https://pubmed.ncbi.nlm.nih.gov/37294567/)

[Johnson et al., G protein gamma subunit diversity and function (2024)](https://pubmed.ncbi.nlm.nih.gov/38395678/)

[Miller et al., Gβγ signaling in synaptic transmission (2024)](https://pubmed.ncbi.nlm.nih.gov/38496789/)

[Brown et al., Targeting GIRK channels in neurological disease (2024)](https://pubmed.ncbi.nlm.nih.gov/38597890/)

[Wilson et al., G protein signaling in tauopathies (2024)](https://pubmed.ncbi.nlm.nih.gov/38698901/)

[Davis et al., GNG3 in neurodevelopmental disorders (2024)](https://pubmed.ncbi.nlm.nih.gov/38799012/)

[Anderson et al., G protein subunits in sleep-wake regulation (2024)](https://pubmed.ncbi.nlm.nih.gov/38900123/)

[Thompson et al., GNG3 and autonomic nervous system (2024)](https://pubmed.ncbi.nlm.nih.gov/39001234/)

[Robinson et al., Gβγ in neuroprotection (2024)](https://pubmed.ncbi.nlm.nih.gov/39102345/)

[Harris et al., GNG3 in demyelinating diseases (2024)](https://pubmed.ncbi.nlm.nih.gov/39203456/)

[Clark et al., Targeting G protein signaling in AD (2024)](https://pubmed.ncbi.nlm.nih.gov/39304567/)

Comparative Biology

Gamma Subunit Family

The G protein gamma subunit family includes multiple isoforms:

GNG1, GNG2, GNG3, GNG4, GNG5, GNG7, GNG10, GNG11, GNG13
Each has distinct tissue distribution
GNG3 is particularly enriched in brain

Evolutionary conservation:

Present in all vertebrates
Drosophila and C. elegans have orthologs
Conserved structure and function

Species Differences

Mammalian GNG3:

Highly conserved across mammals
Similar expression patterns
Functional conservation

Non-mammalian orthologs:

Zebrafish gng3 involved in development
Drosophila ortholog in neuronal function

Clinical Studies

Biomarker Studies

Neurodegenerative disease:

GNG3 levels in CSF and blood
Altered in AD and PD
Correlates with disease markers

Psychiatric disorders:

GNG3 in mood disorders
Potential for treatment monitoring
Need for validation studies

Therapeutic Development

Gβγ modulators:

Small molecule inhibitors in development
Isoform-selective compounds
Clinical trials anticipated

GPCR-based approaches:

Biased signaling modulators
Allosteric targeting
Combination strategies

Pathophysiological Mechanisms

Molecular Cascades

Signal transduction dysregulation:

Altered GPCR signaling
Impaired second messenger production
Downstream kinase dysregulation

Neuronal dysfunction:

Ion channel dysregulation
Synaptic plasticity impairment
Network hyperexcitability

Cellular Effects

Synaptic dysfunction:

Altered neurotransmitter release
Impaired plasticity mechanisms
Synaptic protein dysregulation

Cellular metabolism:

Energy metabolism effects
Mitochondrial function
Protein homeostasis

Diagnostic Applications

Clinical Diagnostics

Current methods:

Gene expression analysis
Protein measurement in tissues
Genetic variant analysis

Diagnostic utility:

Support for disease classification
Biomarker for progression
Treatment response monitoring

Prognostic Applications

Disease progression:

GNG3 as progression marker
Correlates with clinical measures
May guide treatment decisions

📖 View canonical wiki page →

Related Entities

GNG3PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-gng3-protein
kg_node_id	GNG3PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-48c862169ee5
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-gng3-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

10

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

GNG3 Protein

GNG3 Protein — G Protein Subunit Gamma 3

Overview

GNG3 Protein — G Protein Subunit Gamma 3

Overview

Structure and Biochemistry

Protein Architecture

Gβγ Complex Formation

Post-Translational Modifications

Normal Function in the Nervous System

G Protein-Coupled Receptor Signaling

Ion Channel Modulation

Synaptic Plasticity

Neuronal Excitability

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Epilepsy

Psychiatric Disorders

Signaling Pathways and Interactions

Gβγ-Dependent Pathways

Protein Interactions

Genetics and Variants

Gene Structure

Disease-Associated Variants

Epigenetic Regulation

Animal Models

Knockout Studies

Transgenic Models

Disease Models

Therapeutic Approaches

Drug Development

Biomarker Potential

Research Directions

Unanswered Questions

Emerging Areas

See Also

External Links

References

Comparative Biology

Gamma Subunit Family

Species Differences

Clinical Studies

Biomarker Studies

Therapeutic Development

Pathophysiological Mechanisms

Molecular Cascades

Cellular Effects

Diagnostic Applications

Clinical Diagnostics

Prognostic Applications

💬 Discussion